Showing results (1-10 of 436) with videos related to

Sort By:
Pageof 44
Modern Rheumatology|January 7, 2014
Leflunomide: an immunosuppressive drug with multiple effects on T cell functionP Dimitrova, J R Kalden, H Schulze-Koops
Best Practice & Research. Clinical Rheumatology|January 29, 2002
The balance of Th1/Th2 cytokines in rheumatoid arthritisH Schulze-Koops, J R Kalden
Arthritis Research|November 30, 2000
Where is biological therapy going?H Schulze-Koops, J R Kalden
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
What we have learned from trials of immunomodulatory agents in rheumatoid arthritis: Future directionsH Schulze-Koops, H Burkhardt, J R Kalden
Scandinavian Journal of Rheumatology|December 1, 2001
Treatment of rheumatoid arthritis in the third millenniumA Skapenko, J R Kalden, H Schulze-Koops
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Altered memory T cell differentiation in patients with early rheumatoid arthritisA Skapenko, J Wendler, P E Lipsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activationA Skapenko, P E Lipsky, H G Kraetsch, et al.
Rheumatology (Oxford, England)|March 27, 2007
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritisR B Mueller, A Skapenko, J Wendler, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2006
[Superior vena cava syndrome: Catheter association as a rare cause]A J Hueber, J Leipe, A Schmid, et al.
Clinical Immunology and Immunopathology|January 1, 1993
Human CD4 modulation in vivo induced by antibody treatmentG Horneff, A H Guse, H Schulze-Koops, et al.
Pageof 44